TaiMed Biologics Market Cap

TaiMed Biologics has a market cap or net worth of 13.58 billion as of May 8, 2026. Its market cap has decreased by -32.63% in one year.

Market Cap

13.58B

Enterprise Value

12.30B

Revenue

611.35M

Ranking

n/a

PE Ratio

n/a

Stock Price

49.70

Market Cap Chart

Since June 28, 2010, TaiMed Biologics's market cap has increased from 2.58B to 13.58B, an increase of 426.19%. That is a compound annual growth rate of 11.03%.

Market Cap History

Date	Market Cap	% Change
May 8, 2026	13.58B	-18.79%
Dec 31, 2025	16.72B	-28.81%
Dec 31, 2024	23.48B	13.20%
Dec 29, 2023	20.75B	16.27%
Dec 30, 2022	17.84B	0.17%
Dec 30, 2021	17.81B	-16.02%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Lumosa Therapeutics	22.78B
Sunmax Biotechnology	20.80B
Medigen Vaccine Biologics	15.96B
Polaris Group	15.13B
AP Biosciences	14.72B
EirGenix	13.72B
Ever Supreme Bio Technology	12.13B
CHO Pharma	11.68B

Market Cap Rankings